KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Accounts Payables (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Accounts Payables for 17 consecutive years, with $129.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 5.48% to $129.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $129.0 million, a 5.48% increase, with the full-year FY2025 number at $129.0 million, up 5.48% from a year prior.
  • Accounts Payables was $129.0 million for Q4 2025 at Bio-Rad Laboratories, roughly flat from $128.8 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $161.0 million in Q1 2023 to a low of $102.8 million in Q1 2024.
  • A 5-year average of $135.4 million and a median of $136.4 million in 2021 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: tumbled 36.17% in 2024, then skyrocketed 34.21% in 2025.
  • Bio-Rad Laboratories' Accounts Payables stood at $141.9 million in 2021, then fell by 4.86% to $135.0 million in 2022, then increased by 7.08% to $144.6 million in 2023, then fell by 15.42% to $122.3 million in 2024, then rose by 5.48% to $129.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Accounts Payables are $129.0 million (Q4 2025), $128.8 million (Q3 2025), and $139.3 million (Q2 2025).